Skip to content

Vaccine effectiveness of respiratory infectious diseases in Japan

Vaccine effectiveness of respiratory infectious diseases in Japan - Vaccine effectiveness of respiratory infectious diseases in Japan

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000055893
Enrollment
10000
Registered
2024-10-21
Start date
2024-10-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Flu

Interventions

None listed

Sponsors

Nagasaki University
Lead Sponsor
University of Tokyo
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Individuals 18 years of age or older who visit medical facilities with symptoms of suspected respiratory tract infection and individuals 60 years of age or older who are hospitalized with symptoms of suspected respiratory tract infection.

Exclusion criteria

Exclusion criteria: Those refusing to participate in the study Those with an unknown history of COVID-19 vaccination and an unknown history of flu vaccination

Design outcomes

Primary

MeasureTime frame
The effectiveness of COVID-19 vaccine and flu vaccine will be assessed using a test-negative design case-control study (partially using a case-control study) in individuals 18 years of age or older who visit medical facilities with symptoms of suspected respiratory tract infection and in individuals 60 years of age or older who are hospitalized with symptoms of suspected respiratory tract infection.

Countries

Japan

Contacts

Public ContactHaruka Maeda

Institute of Tropical Medicine, Nagasaki University Department of Respiratory Infections

mharuka@nagasaki-u.ac.jp0958197842

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026